Andere talen CSL Limited

Aandelen

CSL

AU000000CSL8

Beurs gesloten - Australian S.E. Andere beurzen 08:10:45 19-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
269,5 ^AUD	-0,70%		-4,33%	-5,99%

12:51	Vifor Pharma biedt aan om concurrentiebeperkend gedrag tegen rivaal recht te zetten	RE
10/04	Mijnbouw stimuleert Australische aandelen; NZ cenbank houdt rente stabiel	RE

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Vifor Pharma offers to rectify anti-competitive behaviour against rival	12:51
Mini brains and lab-on-a-chip wearables: Jumar Bioincubator officially begins its mission to build “Australia’s next CSL”	18/04
Miners boost Australian shares; NZ cenbank keeps rates steady	10/04
New Zealand shares hold gains as c.bank expectedly holds rate; Aussie shares up	10/04
Australian shares rise on mining and healthcare boost; US CPI data, RBNZ in focus	10/04
Australian shares end higher as miners surge; US CPI in focus	09/04
Australian shares fall as financials and healthcare stocks drag	03/04
Australian shares hit record high; RBA cautious on inflation	02/04
Australian shares inch higher; inflation data reinforces subdued rate-cut view	27/03
CSL Prices $1.25 Billion Corporate Bonds Offering	26/03
Miners, healthcare firms push Australia stocks higher	25/03
Ferinject® approved by Health Canada for the treatment of iron deficiency anemia in adult and pediatric patients and iron deficiency in adult patients with heart failure	19/03
Australian shares fall as miners, banks weigh	11/03
Banks drive Australian shares to record high on firming rate-cut bets	08/03
CSL Seqirus Confirms Full Preparation to Implement the Fda's Vaccines and Related Biological Products Advisory Committee	06/03
Australia Health Stocks to Remain at Premium to ASX200, Morgan Stanley Says	06/03
Australian shares skid off record highs to end lower; GDP data awaited	04/03
Australian shares end marginally up as energy, financials offset weak miners	27/02
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatment of IgA Nephropathy	26/02
Australian shares inch lower as banks offset commodity gains	22/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CSL Limited

Aandelen

CSL

AU000000CSL8

Andere talen

Filters